skb571
mAbexperimentalADCBi-specific
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2024 (NCT06725381)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07308106 | Phase 2 | Feb 1, 2026 | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
| NCT07230405 | Phase 2 | Dec 13, 2025 | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
| NCT06725381 | Phase 1 | Dec 31, 2024 | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1